UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2025.
Commission File Number 001-35203
Theratechnologies Inc.
(Translation of registrant’s name into English)
2015 Peel Street, Suite 1100
Montreal, Quebec
H3A
1T8, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
☒ Form 20-F ☐ Form 40-F
EXHIBIT INDEX
|
|
|
| Exhibit No. |
|
Description of Exhibit |
|
|
| 99.1 |
|
Support and Voting Agreement Dated July 2, 2025, Between Andrew Molson and CB Biotechnology, LLC |
|
|
| 99.2 |
|
Support and Voting Agreement Dated July 2, 2025, Between Dale Weil and CB Biotechnology, LLC |
|
|
| 99.3 |
|
Support and Voting Agreement Dated July 2, 2025, Between Dawn Svoronos and CB Biotechnology, LLC |
|
|
| 99.4 |
|
Support and Voting Agreement Dated July 2, 2025, Between Elina Tea and CB Biotechnology, LLC |
|
|
| 99.5 |
|
Support and Voting Agreement Dated July 2, 2025, Between Frank Holler and CB Biotechnology, LLC |
|
|
| 99.6 |
|
Support and Voting Agreement Dated July 2, 2025, Between Jordan Zwick and CB Biotechnology, LLC |
|
|
| 99.7 |
|
Support and Voting Agreement Dated July 2, 2025, Between Joseph Arena and CB Biotechnology, LLC |
|
|
| 99.8 |
|
Support and Voting Agreement Dated July 2, 2025, Between Paul Lévesque and CB Biotechnology, LLC |
|
|
| 99.9 |
|
Support and Voting Agreement Dated July 2, 2025, Between Christian Marsolais and CB Biotechnology, LLC |
|
|
| 99.10 |
|
Support and Voting Agreement Dated July 2, 2025, Between Jocelyn Lafond and CB Biotechnology, LLC |
|
|
| 99.11 |
|
Support and Voting Agreement Dated July 2, 2025, Between John Leasure and CB Biotechnology, LLC |
|
|
| 99.12 |
|
Support and Voting Agreement Dated July 2, 2025, Between Philippe Dubuc and CB Biotechnology, LLC |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THERATECHNOLOGIES INC. |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Jocelyn Lafond |
|
|
|
|
|
|
Name: |
|
Jocelyn Lafond |
|
|
|
|
|
|
Title: |
|
General Counsel and Corporate Secretary |
Date: July 9, 2025
